Works matching IS 19450877 AND DT 2014 AND VI 7 AND IP 339


Results: 4
    1
    2
    3
    4

    The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.

    Published in:
    Science Signaling, 2014, v. 7, n. 339, p. 1, doi. 10.1126/scisignal.2005157
    By:
    • Tai Kiuchi;
    • Ortiz-Zapater, Elena;
    • Monypenny, James;
    • Matthews, Daniel R.;
    • Nguyen, Lan K.;
    • Barbeau, Jody;
    • Coban, Oana;
    • Lawler, Katherine;
    • Burford, Brian;
    • Rolfe, Daniel J.;
    • de Rinaldis, Emanuele;
    • Dafou, Dimitra;
    • Simpson, Michael A.;
    • Woodman, Natalie;
    • Pinder, Sarah;
    • Gillett, Cheryl E.;
    • Devauges, Viviane;
    • Poland, Simon P.;
    • Fruhwirth, Gilbert;
    • Marra, Pierfrancesco
    Publication type:
    Article